Elizabethkingia meningosepticum has been reported in cases of pneumonia, endocarditis, wound infections, post-operative bacteraemia and meningitis. It usually affects patients with severe underlying illness/immunocompromised host. An 18-yearold female, presented with a history of fever, cough, expectoration, loss of appetite and breathlessness for two weeks. Diagnostic evaluation revealed right-sided pleural effusion with consolidation. In view of patient being an inmate at residential facility for homeless where prevalence of tuberculosis (TB) was high, anti-TB treatment was empirically initiated. Pleural fluid later grew a Gram-negative non-fermenter, identified as Elizabethkingia meningosepticum.
Steinberg JP, Burd EM. Other Gram negative and Gram variable bacilli. In: Mandell GL, Bennett JE, Dolin R, editors - Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone; 2010: pp 3015–33.
Kim KK, Kim MK, Lim JH, Park HY, Lee ST. Transfer of Chryseobacterium meningosepticum and Chryseobacterium miricola to Elizabethkingia gen. nov. as Elizabethkingia meningoseptica comb. nov. and Elizabethkingia miricola comb. nov. Int J Syst Evol Microbiol 2005;55:1287-93.
Abrahamsen TG, Finne PH, Lingaas E. Flavobacterium meningosepticum infections in a neonatal intensive care unit. Acta Paediatrica Scandinavia 1989;78:51–5.
The Nonfermentated Gram-Negative bacilli. In: Procop GW, Church DL, Hall GS, Janda WM, Koneman EW, Schreckenberger PC et al, editors Koneman's Colour Atlas and Textbook of Diagnostic Microbiology. Philadelphia: Walter Kluwer 2017; pp 317-408.
Clinical and Laboratory Standards Institute (CLSI) document M100-S25. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fifth Informational Supplement. January 2016. Available at URL: http://clsi.org. Accessed on: October 24, 2016.
Ghafur A, Vidyalakshmi PR, Priyadarshini K, Easow JM, Raj R, Raja T. Elizabethkingia meningoseptica bacteremia in immunocompromised hosts: the first case series from India. South Asian J Cancer 2013;2:211–5.
Ratnamani MS, Rao R. Elizabethkingia meningoseptica: Emerging nosocomial pathogen in bedside hemodialysis patients. Indian J Crit Care Med 2013;17:304–7.
Pereira GH, Garcia DO, Abboud CS, Barbosa VLB, Silva PSL. Nosocomial infections caused by Elizabethkingia meningoseptica: an emergent pathogen. Brazilian J Infect Dis 2013;17:606–9.
Kim DH, Rhee J, Kim YS, Park JS, Jee YK, Lim J. Experience of Elizabethkingia meningoseptica infection at a tertiary hospital in South Korea. Am J Respir Crit Care Med 2014;189:A6239.
Sarangi G, Patnaik G, Das P, Chayani N, Patnaik J. Tubercular pleural effusion complicated with Elizabethkingia meningoseptica infection in a diabetic male. Indian J Pathol Microbiol 2015;58:130–2.
Lee SW, Tsai CA, Lee BJ. Chryseobacterium meningosepticum sepsis complicated with retroperitoneal hematoma and pleural effusion in a diabetic patient. J Chin Med Assoc 2008;71:473–6.
Gnanasoundran V, Fernando EM, Kumar S, Kumar R, Valavan T, Mohan C, et al. Chryseobacterium meningosepticum in a parapneumonic effusion in a chronic kidney disease patient on hemodialysis. Hemodial Int 2014;18:835–8.
Tak V, Mathur P, Varghese P, Misra MC. Elizabethkingia meningoseptica: an emerging pathogen causing meningitis in a hospitalized adult trauma patient. Indian J Med Microbiol 2013;31:293–5.
Joo HD, Ann SY, Ryou SH, Kim YS, Kim JW, Kim DH. Experience with Elizabethkingia meningoseptica infection in adult patients at a tertiary hospital. Korean J Crit Care Med 2015;30:241–8.
Bellais S, Poire L, Naas T, Girlich D, Nordmann P. Genetic biochemical analysis and distribution of the Ambler class A-lactamase CME-2, responsible for extended spectrum cephalosporin resistance in Elizabethkingae (Flavobacterium) meningosepticum. Antimicrob Agents Chemother 2000;44:1–9.
Chen GX, Zhang RH, Zhou W. Heterogeneity of metallo- â-lactamases in clinical isolates of Elizabethkingae meningosepticum from Hangzhou China. J Antimicrb Chemother 2006;57:750–2.
